The $9.8 million settlement NeoGenomics reached with the DOJ traces back to a voluntary disclosure the company made to the Office of Inspector General of the U.S. Department of Health and Human Services in Nov. 2021. The investigation centered on consulting services tied to laboratory testing under the company's Laboratory Collaboration Initiative program. The DOJ acknowledged in the settlement agreement that NeoGenomics cooperated with the government's investigation. The agreement isn't an admission of liability by the company nor a concession by the government that its claims lacked merit.

This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.

(END) Dow Jones Newswires

July 20, 2026 17:46 ET (21:46 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.